Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ewa Robak

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Mediators of Inflammation|February 6, 2004
Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosusEwa Robak, Anna Sysa-Jedrzejewska, Tadeusz Robak
Postepy Higieny I Medycyny Doswiadczalnej (Online)|September 6, 2007
[Quality of life in systemic lupus erythematosus patients, with a particular description of methodology]Lilianna Kulczycka, Anna Sysa-Jedrzejowska, Ewa Robak
Przeglad Lekarski|March 18, 2006
[Progress and perspectives in the treatment of systemic lupus erythematosus]Ewa Robak, Anna Sysa-Jedrzejowska, Anna Wozniacka
Przeglad Lekarski|December 13, 2005
[Diagnostic problems and evaluation of disease activity in systemic lupus erythematosus]Ewa Robak, Aneta Kwiecień, Anna Sysa-Jedrzejowska
Recent Patents on Anti-Cancer Drug Discovery|November 30, 2010
Novel systemic drugs for cutaneous T-cell lymphomaEwa Lech-Maranda, Ewa Robak, Tadeusz Robak
Postepy Higieny I Medycyny Doswiadczalnej (Online)|August 1, 2009
[TLR function in autoimmunological processes]Agnieszka Klonowska-Szymczyk, Anna Wolska, Ewa Robak
Postepy Dermatologii I Alergologii|February 19, 2021
The role of endocan and selected pro-inflammatory cytokines in systemic lupus erythematosusKamila Tokarska, Jarosław Bogaczewicz, Ewa Robak, et al.
Journal of Clinical Medicine|August 10, 2024
Psoriasis and Lupus Erythematosus-Similarities and Differences between Two Autoimmune DiseasesAleksandra Fijałkowska, Joanna Wojtania, Anna Woźniacka, et al.
Annals of Hematology|July 25, 2024
Extramedullary and extranodal manifestations in chronic lymphocytic leukemia - an updateTadeusz Robak, Anna Puła, Marcin Braun, et al.
Journal of Clinical Medicine|February 10, 2024
Primary Cutaneous CD30-Positive Lymphoproliferative Disorders-Current Therapeutic Approaches with a Focus on Brentuximab VedotinTomasz Stein, Tadeusz Robak, Wojciech Biernat, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Mediators of Inflammation|February 6, 2004
Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosusEwa Robak, Anna Sysa-Jedrzejewska, Tadeusz Robak
Postepy Higieny I Medycyny Doswiadczalnej (Online)|September 6, 2007
[Quality of life in systemic lupus erythematosus patients, with a particular description of methodology]Lilianna Kulczycka, Anna Sysa-Jedrzejowska, Ewa Robak
Przeglad Lekarski|March 18, 2006
[Progress and perspectives in the treatment of systemic lupus erythematosus]Ewa Robak, Anna Sysa-Jedrzejowska, Anna Wozniacka
Przeglad Lekarski|December 13, 2005
[Diagnostic problems and evaluation of disease activity in systemic lupus erythematosus]Ewa Robak, Aneta Kwiecień, Anna Sysa-Jedrzejowska
Recent Patents on Anti-Cancer Drug Discovery|November 30, 2010
Novel systemic drugs for cutaneous T-cell lymphomaEwa Lech-Maranda, Ewa Robak, Tadeusz Robak
Postepy Higieny I Medycyny Doswiadczalnej (Online)|August 1, 2009
[TLR function in autoimmunological processes]Agnieszka Klonowska-Szymczyk, Anna Wolska, Ewa Robak
Postepy Dermatologii I Alergologii|February 19, 2021
The role of endocan and selected pro-inflammatory cytokines in systemic lupus erythematosusKamila Tokarska, Jarosław Bogaczewicz, Ewa Robak, et al.
Journal of Clinical Medicine|August 10, 2024
Psoriasis and Lupus Erythematosus-Similarities and Differences between Two Autoimmune DiseasesAleksandra Fijałkowska, Joanna Wojtania, Anna Woźniacka, et al.
Annals of Hematology|July 25, 2024
Extramedullary and extranodal manifestations in chronic lymphocytic leukemia - an updateTadeusz Robak, Anna Puła, Marcin Braun, et al.
Journal of Clinical Medicine|February 10, 2024
Primary Cutaneous CD30-Positive Lymphoproliferative Disorders-Current Therapeutic Approaches with a Focus on Brentuximab VedotinTomasz Stein, Tadeusz Robak, Wojciech Biernat, et al.
Pageof 8